Anzeige
Erschienen in:
01.11.2010 | Symposium: Highlights of the ISOLS/MSTS 2009 Meeting
The Survivorship of Protrusio Cages for Metastatic Disease Involving the Acetabulum
Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 11/2010
Einloggen, um Zugang zu erhaltenAbstract
Background
Metastatic disease commonly affects the proximal femur and occasionally the acetabulum. Surgical options include the use of a protrusio cage with a THA. However, the complications and survivorship of these cages for this indication is unknown.
Questions/purposes
The purpose was to report the restoration of function, complications and implant survival.
Methods
The medical records of 29 patients undergoing insertion of a protrusio cage for metastatic pelvic disease were reviewed. Complications were recorded. The most common diagnosis was metastatic breast cancer. During the review process, all but 10 of the 29 patients died 1–73 months after surgery. The median length of survival was 12 months (range, 3 days–100 months) after the procedure; 11 patients were alive at last followup at a median of 16 months (range, 1–100 months).
Results
One patient had loss of fixation owing to disease progression. Five patients had dislocations, four of which were treated. There were three deep infections (two that led to dislocation, which proceeded to revision surgery). Ten patients of the 29 patients became household ambulators, 17 became community ambulators, two remained chair-bound, and one bed-bound.
Conclusions
The protrusio cage allowed most patients to return to walking with only one mechanical failure.
Level of Evidence
Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.